| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/22/2012 | EP2420491A1 3 , 5-substitued piperidine compounds as renin inhibitors |
| 02/22/2012 | EP2420245A1 Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth |
| 02/22/2012 | EP2420234A1 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position as PARP inhibitors for use in treating cancer |
| 02/22/2012 | EP2420233A2 Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats |
| 02/22/2012 | EP2420232A2 Angiotensin II receptor antagonist for the prevention or treatment of cardiovascular diseases in cats |
| 02/22/2012 | EP2420231A2 Angiotensin II receptor antagonist for the prevention or treatment of cardiovascular disease in cats |
| 02/22/2012 | EP2419421A1 Process for preparation of endothelial receptor antagonist (bosentan) |
| 02/22/2012 | EP2419403A1 Vitamin d receptor agonists and uses thereof |
| 02/22/2012 | EP2419122A2 Methods of inhibiting adverse cardiac events and treating atherosclerosis and coronary artery disease using galectin-3 binding protein (gal-3bp, btbd17b, mac-2 binding protein) |
| 02/22/2012 | EP2419114A1 Bacterial compositions for prophylaxis and treatment of degenerative disease |
| 02/22/2012 | EP2419103A1 Use of multi-kinase inhibitors in the treatment of vascular hyperpermeability |
| 02/22/2012 | EP2419097A1 Pharmaceutical compositions |
| 02/22/2012 | EP2371840A9 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes |
| 02/22/2012 | EP2326644B1 Urotensin ii receptor antagonists |
| 02/22/2012 | EP2093228B1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 02/22/2012 | EP1995240B1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 02/22/2012 | EP1853280B1 Compositions and methods for treating and preventing cardiomyopathy and heart disease |
| 02/22/2012 | EP1799268B1 Magnetic particles for therapy and diagnosis |
| 02/22/2012 | EP1648494B1 Anti-angiogenetic agent and its use in cancer treatment |
| 02/22/2012 | EP1558226B1 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 02/22/2012 | EP0986384B1 Inhibitors of protein isoprenyl transferases |
| 02/22/2012 | CN202146434U 一种降压药组合物 An antihypertensive drug composition |
| 02/22/2012 | CN1903250B 一种丹参药材的提取分离方法 A method for the extraction and separation of herbs Salvia |
| 02/22/2012 | CN102361979A Peptide capable of binding to immunoglobulin |
| 02/22/2012 | CN102358741A Azepinoindole derivatives as pharmaceutical agents |
| 02/22/2012 | CN102358735A Low toxicity multiple independently target able drugs-nitrogen aromatic ring-containing CB1 receptor inhibitor with hydroxyl or substituted hydroxyl, and pharmaceutical use thereof |
| 02/22/2012 | CN102358730A Micromolecular methyl ethyl ketone (MEK) protein kinase inhibitor |
| 02/22/2012 | CN102358721A More stable aceglutamide compound and medicinal composition thereof |
| 02/22/2012 | CN102357247A Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 02/22/2012 | CN102357240A Traditional Chinese medicine for treating peripheral vascular functional disease of Raynaud disease |
| 02/22/2012 | CN102357231A Quality control method of compound fructus embeliae haemorrhoid suppository and preparation thereof |
| 02/22/2012 | CN102357220A Traditional Chinese medicine composition for treating early-stage lower limb thrombotic deep phlebitis |
| 02/22/2012 | CN102357208A Traditional Chinese medicine composition for treating diabetes, hyperglycemia, hypertension, and hyperlipidemia |
| 02/22/2012 | CN102357207A Traditional Chinese medicine composition for curing hypertension |
| 02/22/2012 | CN102357206A Mountain toad detumescence mass-dissipating detoxication pellets and preparation method |
| 02/22/2012 | CN102357201A Traditional Chinese medicine composition for treating venous injury, and preparation method and application thereof |
| 02/22/2012 | CN102357195A Medicinal composition for treating cardiovascular and cerebrovascular diseases, and preparation method and application thereof |
| 02/22/2012 | CN102357174A Chinese patent drug for invigorating circulation of blood and promoting circulation of qi |
| 02/22/2012 | CN102357152A Chinese medicine composite for treating formation of cerebral thrombosis |
| 02/22/2012 | CN102357138A Red sage root-panax notoginseng pill |
| 02/22/2012 | CN102357125A Chinese herbal medicine composition for treating early occlusive peripheral atherosclerosis |
| 02/22/2012 | CN102357118A Extraction method of salvia extract and safflower extract and preparation method of salvia-safflower oral preparation |
| 02/22/2012 | CN102357095A Stable medicinal composition |
| 02/22/2012 | CN102357087A Metoprolol fumarate sustained-release tablet and preparation method thereof |
| 02/22/2012 | CN102357084A Enalapril maleate tablet composition and its preparation and use |
| 02/22/2012 | CN102357083A Preparation method of salvia tetramethylpyrazine freeze-dried powder injection preparation for injection |
| 02/22/2012 | CN102357078A Valsartan solid dispersion and preparation method thereof |
| 02/22/2012 | CN102356789A Blood press reduction health-care tea |
| 02/22/2012 | CN102070617B 坎地沙坦酯化合物及其新制法 Candesartan cilexetil compounds and freshly France |
| 02/22/2012 | CN102018660B 萘哌地尔栓剂及其制备方法 Naftopidil suppositories and its preparation method |
| 02/22/2012 | CN101862329B 一种氨氯地平阿托伐他汀钙药物组合物脂质体固体制剂 One kind of amlodipine atorvastatin calcium pharmaceutical composition of the solid preparation of liposomes |
| 02/22/2012 | CN101805285B 含烟酸姜黄素酯衍生物及其制造方法和用途 Nicotinic acid ester derivatives containing curcumin and its manufacturing method and use thereof |
| 02/22/2012 | CN101721435B 一种灵芝孢子粉纳米硒复合物及其制备方法 One kind of fungus spores on nano selenium compound and preparation method |
| 02/22/2012 | CN101407557B 一种金钗石斛多糖提取物的制备和应用 A preparation and application of Dendrobium nobile polysaccharide extract |
| 02/22/2012 | CN101323613B 一种小檗碱加成物、含有该加成物的药物及其制备方法 One kind of berberine adducts, adducts containing the drug and its preparation method |
| 02/22/2012 | CN101247794B 阿肽地尔的制剂 A peptide formulations Seoul |
| 02/22/2012 | CN101176751B 丹参和桂枝的药物组合物 Salvia and pharmaceutical compositions Guizhi |
| 02/22/2012 | CN101085071B 含有丹参、山楂的中药组合物及其制剂 Containing Salvia, hawthorn herbal compositions and preparations |
| 02/22/2012 | CN101084996B 含有丹参的中药组合物及其制剂 Chinese medicine composition containing Salvia and its preparations |
| 02/22/2012 | CN101084994B 一种含有丹参和人参的药物组合物、制备方法和制剂 The pharmaceutical compositions containing Salvia and ginseng, preparation methods and formulations |
| 02/21/2012 | US8119819 Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators |
| 02/21/2012 | US8119687 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 02/21/2012 | US8119678 Compounds, compositions and methods |
| 02/21/2012 | US8119665 Aryl imidazoles and related compounds as C5a receptor modulators |
| 02/21/2012 | US8119658 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| 02/21/2012 | US8119597 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 02/21/2012 | US8119590 Apolipoprotein A-I (ApoA-I), preferably a variant form such as Apolipoprotein A-I Milano (ApoA-IM), alone or more preferably in combination with a lipid carrier such as phospholipids or other drug, can be administered locally |
| 02/21/2012 | US8119397 Therapeutic agents and therapeutic methods for treating injured tissue |
| 02/21/2012 | US8119121 Delivering a concentrated amount of stem cells obtained from adipose tissue to a patient |
| 02/21/2012 | CA2529207C 2,4-bis(trifluoroethoxy)pyridine compound and medicine containing the same |
| 02/21/2012 | CA2488372C Pyridazine derivatives which are phosphodiasterase iv inhibitors |
| 02/21/2012 | CA2478542C Aminoindazole derivatives, their method of preparation and intermediaries of this process as medicines and pharmaceutical compositions containing same |
| 02/21/2012 | CA2472399C Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 02/21/2012 | CA2451981C 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 02/21/2012 | CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/21/2012 | CA2418962C Anti-dual integrin antibodies, compositions, methods and uses |
| 02/21/2012 | CA2400141C Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof |
| 02/21/2012 | CA2398940C Methods and compositions using stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 02/21/2012 | CA2394716C Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 02/21/2012 | CA2373300C Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 02/21/2012 | CA2349760C Bovine cells expressing adeno virus essential functions for propagation of recombinant adenoviral vectors |
| 02/21/2012 | CA2322055C Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 02/16/2012 | WO2012021830A1 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors |
| 02/16/2012 | WO2012021647A2 Modulators of nod1 and nod2 signaling, methods of identifying modulators of nod1 and nod2 signaling, and uses thereof |
| 02/16/2012 | WO2012020726A1 Inhibitor of casein kinase 1δ and casein kinase 1ε |
| 02/16/2012 | WO2012020566A1 Highly functionalized stem cell/progenitor cell by ape1 gene transfection |
| 02/16/2012 | WO2012020422A1 A novel herbal formulation advocated for the prevention and management of coronary heart disease |
| 02/16/2012 | WO2012020227A1 Tricyclic compounds for use as kinase inhibitors |
| 02/16/2012 | WO2012020217A1 Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors |
| 02/16/2012 | WO2012020215A1 Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors |
| 02/16/2012 | WO2012020040A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions |
| 02/16/2012 | WO2012019479A1 Effective fraction from the fruiting bodies of ganoderma lucidum, extraction method, use and preparation thereof |
| 02/16/2012 | WO2012019428A1 Benzohydrol derivatives, a preparation process and pharmaceutical use thereof |
| 02/16/2012 | WO2012019381A1 Oral pharmaceutical composition containing inclusion of edaravone and cyclodextrin and preparation method thereof |
| 02/16/2012 | WO2012019237A1 Therapeutic method for treating congestive heart failure |
| 02/16/2012 | WO2011143360A3 Compositions, methods and systems for the synthesis and use of imaging agents |
| 02/16/2012 | WO2011140655A8 Phenolic compositions derived from apple skin and uses thereof |
| 02/16/2012 | WO2011129719A3 Method for preparation of a cardiomyocyte matrix |
| 02/16/2012 | US20120041068 Extended Release Pharmaceutical Preparations for Active Pharmaceutical Ingredients with pH Dependent Solubility |
| 02/16/2012 | US20120041062 Compound of salvianolic acid l, preparation method and use thereof |